Search Within

Victoria M Richon

Formats
  1. Journal Article (49)
  2. Meeting Abstract (37)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Surgery (11)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Solid Tumor Oncology Division (8)
  5. Genitourinary Oncology Service (6)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Paul Marks (77)
  2. Richard Rifkind (76)
  3. Xianbo Zhou (11)
  4. Carlos Cordon-Cardo (10)
  5. Hiroaki Kiyokawa (9)
  6. Gisela Venta-Perez (8)

More People

Years
  1. 2004 (2)
  2. 2003 (3)
  3. 2002 (6)
  4. 2001 (11)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (20)
  2. Proceedings of the National Academy of Sciences of the United States of America (11)
  3. Blood (8)
  4. Cancer Research (7)
  5. Clinical Cancer Research (6)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (35)
  2. National Academy of Sciences (11)
  3. American Society of Hematology (8)
  4. International Institute of Anticancer Research (5)
  5. Nature Publishing Group (4)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitor activation of p21 involves changes in promoter associated proteins, including HDAC1
    Meeting Abstract

    Gui, C.; Ngo, L.; Xu, W.; Thapi, D.; Perez, G. V.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Assays to assess effectiveness in vitro and in vivo
    Journal Article

    Richon, V. M.; Zhou, X.; Secrist, J. P.; Cordon-Cardo, C.; Kelly, W. K.; Drobnjak, M.; Marks, P. A.
    Methods in Enzymology (2004)

    Fulltext@MSK | Save
  • Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W. K.; O'connor, O.; Richon, V. M.; Curley, T.; Richardson, S.; Thapi, D.; Chiao, J. H.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Molecular sequelae of histone deacetylase inhibition in human malignant B cells
    Journal Article

    Mitsiades, N.; Mitsiades, C. S.; Richardson, P. G.; McMullan, C.; Poulaki, V.; Fanourakis, G.; Schlossman, R.; Chauhan, D.; Munshi, N. C.; Hideshima, T.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro
    Journal Article

    Kutko, M. C.; Glick, R. D.; Butler, L. M.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; LaQuaglia, M. P.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Differentiation and the role of differentiation inducers in cancer treatment
    Book Section

    Rifkind, R.; Richon, V.; Marks, P. A.; Breslow, R.
    In Bertino, J. R. (Eds.) Encyclopedia of Cancer. 2nd ed (2002)

    Fulltext@MSK | Save
  • Cloning and characterizing of HDAC9 and its alternatively spliced isoforms
    Meeting Abstract

    Zhou, X.; Marks, P. A.; Rifkind, R. A.; Richon, V. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces thioredoxin-binding protein-2 which blocks thioredoxin function
    Meeting Abstract

    Butler, L. M.; Zhou, X.; Scher, H. I.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors and the treatment of cancers
    Meeting Abstract

    Rifkind, R. A.; Richon, V.; Breslow, R.; Marks, P. A.
    Abstracts of Papers of the American Chemical Society (2002)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors
    Journal Article

    Cohen, L. A.; Marks, P. A.; Rifkind, R. A.; Amin, S.; Desai, D.; Pittman, B.; Richon, V. M.
    Anticancer Research (2002)

    Fulltext@MSK | Save